UCI-1 is a SARS-CoV-2 main protease (Mpro) cyclic peptide inhibitor with an IC50 of 160 µM. UCI-1 shows no obvious cytotoxicity at the concentration of inhibiting Mpro. UCI-1 can be used in the study of anti-COVID-19 drugs[1].
Molecular Weight:
651.75
Formula:
C33H45N7O7
Target:
SARS-CoV,Virus Protease
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
